Related Experiment Videos
Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study
C P Archibald1, M T Schechter, K J Craib
1Vancouver Lymphadenopathy-AIDS Study Group, St. Paul's Hospital, B.C. Canada.
Abstract:
In our ongoing cohort study of homosexual men, the ratio of new Kaposi's sarcoma (KS) cases to new opportunistic infections (OI) during the periods 1982-1985, 1986-1987, and 1988-1989 fell from 0.75 (9 KS: 12 OI) to 0.57 (12 KS:21 OI) to 0.27 (4 KS:15 OI), respectively. To examine factors associated with the development of KS as compared to OI, we compared antecedent risk factors in 25 KS cases and 48 OI "controls." In univariate analyses, several classical HIV risk factors including numbers of sexual partners and receptive anal intercourse were higher in the KS than the OI group. The strongest associations were found with an elevated number of sex partners in high-risk areas (San Francisco, Los Angeles, and New York) in the 5 years prior to enrollment and with elevated use of nitrite inhalants. Logistic regression revealed the latter two variables and an elevated number of partners contacted in washrooms/parks to be significant, independent risk factors for KS relative to OI. Any or all of these variables could be related with early HIV infection. However, the association with early sexual contact in high-risk areas raises the more intriguing possibility that this variable is an indicator of an increased exposure either to a particular strain of HIV that is more pathogenic for KS, or, more likely, to a sexually transmitted KS cofactor that may have been more highly concentrated in these areas at this early point in the epidemic. The present study supports an independent association with use of nitrite inhalants, which could be hypothesized either to have an independent biologic effect on KS or to enhance the efficiency of transmission of the cofactor virus.
Insights
This study found that increased sexual partners in high-risk areas and nitrite inhalant use were associated with Kaposi's sarcoma (KS) compared to opportunistic infections (OI) in homosexual men. These factors may indicate exposure to a more pathogenic HIV strain or a KS cofactor.
Area of Science:
- Epidemiology
- Infectious Diseases
- Oncology
Background:
- Kaposi's sarcoma (KS) and opportunistic infections (OI) are major complications of Human Immunodeficiency Virus (HIV) infection.
- The relative incidence of KS to OI has changed over time in the early HIV epidemic.
- Understanding risk factors for KS versus OI is crucial for patient management and disease understanding.
Purpose of the Study:
- To identify antecedent risk factors associated with the development of Kaposi's sarcoma (KS) compared to opportunistic infections (OI) in homosexual men.
- To investigate the role of sexual behavior, geographic location, and substance use in KS development.
- To explore potential links between HIV strain, co-infections, and KS pathogenesis.
Main Methods:
- A cohort study comparing risk factors in 25 KS cases and 48 OI controls.
- Univariate and logistic regression analyses were used to assess associations.
- Data collected included number of sexual partners, sexual practices, geographic location of partners, and substance use (nitrite inhalants).
Main Results:
- Higher numbers of sexual partners and receptive anal intercourse were observed in the KS group.
- Significant independent risk factors for KS relative to OI included: elevated number of sex partners in high-risk areas (San Francisco, Los Angeles, New York) and elevated nitrite inhalant use.
- Contact with partners in washrooms/parks was also a significant independent risk factor.
Conclusions:
- Nitrite inhalant use is independently associated with KS, potentially through direct biological effects or enhanced cofactor transmission.
- Sexual contact in high-risk areas may indicate exposure to a more pathogenic HIV strain or a sexually transmitted KS cofactor.
- These findings highlight the complex interplay of HIV, behavioral factors, and potential co-exposures in the pathogenesis of Kaposi's sarcoma.